Hawaii Biotech, Inc. Email Format

Biotechnology ResearchHawaii, United States11-50 Employees

Hawaii Biotech, Inc. is a privately held biotechnology company based in Honolulu, Hawaii, focused on research and development of vaccines for established and emerging infectious diseases. It has built proprietary capabilities for producing recombinant proteins used in vaccine development, and its portfolio includes vaccine candidates in clinical or pre-clinical development targeting West Nile virus, tick-borne flaviviruses, Zika, Crimean-Congo hemorrhagic fever virus, and Chikungunya. In addition to vaccines, the company pursues small molecule therapies aimed at blocking bacterial toxins, with potential anti-toxin agents for Bacillus anthracis and botulinum toxin, and it collaborates on a proprietary saponin adjuvant for vaccine development.

Hawaii Biotech operates within the biotechnology research sector, positioning its work at the intersection of vaccine science and biodefense applications. In 2021 the company announced the retirement of its president and chief executive officer for medical reasons. Public reports in recent years also note the company's involvement in COVID-19 vaccine development as part of its broader vaccine program.

Sign up for free to view info

Company overview Employee directory